annual CFO:
$6.66M+$21.86M(+143.85%)Summary
- As of today (June 22, 2025), TXG annual cash flow from operations is $6.66 million, with the most recent change of +$21.86 million (+143.85%) on December 31, 2024.
- During the last 3 years, TXG annual CFO has risen by +$28.04 million (+131.18%).
- TXG annual CFO is now -80.75% below its all-time high of $34.63 million, reached on December 31, 2019.
Performance
TXG Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$34.35M+$41.10M(+609.05%)Summary
- As of today (June 22, 2025), TXG quarterly cash flow from operations is $34.35 million, with the most recent change of +$41.10 million (+609.05%) on March 31, 2025.
- Over the past year, TXG quarterly CFO has increased by +$50.08 million (+318.45%).
- TXG quarterly CFO is now at all-time high.
Performance
TXG quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$56.74M+$50.08M(+751.44%)Summary
- As of today (June 22, 2025), TXG TTM cash flow from operations is $56.74 million, with the most recent change of +$50.08 million (+751.44%) on March 31, 2025.
- Over the past year, TXG TTM CFO has increased by +$83.54 million (+311.74%).
- TXG TTM CFO is now at all-time high.
Performance
TXG TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
TXG Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +143.8% | +318.4% | +311.7% |
| 3 y3 years | +131.2% | +265.1% | +248.9% |
| 5 y5 years | -80.8% | +1433.5% | +149.6% |
TXG Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +119.8% | at high | +235.8% | at high | +197.5% |
| 5 y | 5-year | -80.8% | +103.1% | at high | +126.4% | at high | +125.9% |
| alltime | all time | -80.8% | +103.1% | at high | +126.4% | at high | +125.9% |
TXG Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $34.35M(-609.1%) | $56.74M(+751.4%) |
| Dec 2024 | $6.66M(-143.9%) | -$6.75M(-131.2%) | $6.66M(-83.0%) |
| Sep 2024 | - | $21.64M(+188.7%) | $39.17M(-603.8%) |
| Jun 2024 | - | $7.50M(-147.7%) | -$7.78M(-71.0%) |
| Mar 2024 | - | -$15.72M(-161.0%) | -$26.80M(+76.3%) |
| Dec 2023 | -$15.20M(-54.8%) | $25.76M(-201.8%) | -$15.20M(-44.2%) |
| Sep 2023 | - | -$25.30M(+119.5%) | -$27.23M(+137.0%) |
| Jun 2023 | - | -$11.53M(+179.4%) | -$11.49M(-32.1%) |
| Mar 2023 | - | -$4.13M(-130.1%) | -$16.93M(-49.6%) |
| Dec 2022 | -$33.61M(+57.2%) | $13.72M(-243.5%) | -$33.61M(-19.1%) |
| Sep 2022 | - | -$9.56M(-43.6%) | -$41.52M(-28.6%) |
| Jun 2022 | - | -$16.96M(-18.5%) | -$58.18M(+52.7%) |
| Mar 2022 | - | -$20.80M(-458.3%) | -$38.09M(+78.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$21.37M(-90.2%) | $5.80M(-122.1%) | -$21.37M(-86.4%) |
| Sep 2021 | - | -$26.22M(-940.3%) | -$157.35M(-15.7%) |
| Jun 2021 | - | $3.12M(-176.4%) | -$186.77M(-14.9%) |
| Mar 2021 | - | -$4.08M(-96.9%) | -$219.40M(+0.7%) |
| Dec 2020 | -$217.90M(-729.3%) | -$130.18M(+134.0%) | -$217.90M(+168.9%) |
| Sep 2020 | - | -$55.63M(+88.5%) | -$81.02M(+645.5%) |
| Jun 2020 | - | -$29.52M(+1045.9%) | -$10.87M(-147.8%) |
| Mar 2020 | - | -$2.58M(-138.4%) | $22.73M(-34.3%) |
| Dec 2019 | $34.63M(-145.3%) | $6.70M(-53.9%) | $34.63M(+24.0%) |
| Sep 2019 | - | $14.53M(+255.8%) | $27.93M(+108.4%) |
| Jun 2019 | - | $4.08M(-56.2%) | $13.40M(+43.8%) |
| Mar 2019 | - | $9.32M | $9.32M |
| Dec 2018 | -$76.41M(+614.2%) | - | - |
| Dec 2017 | -$10.70M | - | - |
FAQ
- What is 10x Genomics annual cash flow from operations?
- What is the all time high annual CFO for 10x Genomics?
- What is 10x Genomics annual CFO year-on-year change?
- What is 10x Genomics quarterly cash flow from operations?
- What is the all time high quarterly CFO for 10x Genomics?
- What is 10x Genomics quarterly CFO year-on-year change?
- What is 10x Genomics TTM cash flow from operations?
- What is the all time high TTM CFO for 10x Genomics?
- What is 10x Genomics TTM CFO year-on-year change?
What is 10x Genomics annual cash flow from operations?
The current annual CFO of TXG is $6.66M
What is the all time high annual CFO for 10x Genomics?
10x Genomics all-time high annual cash flow from operations is $34.63M
What is 10x Genomics annual CFO year-on-year change?
Over the past year, TXG annual cash flow from operations has changed by +$21.86M (+143.85%)
What is 10x Genomics quarterly cash flow from operations?
The current quarterly CFO of TXG is $34.35M
What is the all time high quarterly CFO for 10x Genomics?
10x Genomics all-time high quarterly cash flow from operations is $34.35M
What is 10x Genomics quarterly CFO year-on-year change?
Over the past year, TXG quarterly cash flow from operations has changed by +$50.08M (+318.45%)
What is 10x Genomics TTM cash flow from operations?
The current TTM CFO of TXG is $56.74M
What is the all time high TTM CFO for 10x Genomics?
10x Genomics all-time high TTM cash flow from operations is $56.74M
What is 10x Genomics TTM CFO year-on-year change?
Over the past year, TXG TTM cash flow from operations has changed by +$83.54M (+311.74%)